-
Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex.
Department of Pathology, University of Alabama at Birmingham 35294.
The crystal structure of calmodulin (CaM) bound to trifluoperazine (TFP) has been determined and refined to a resolution of 2.45 A. Only one TFP is bound to CaM, but that is sufficient to cause distortion of the central alpha-helix and juxtaposition of the N- and C-terminal domains similar to that seen in CaM-polypeptide complexes. The drug makes extensive contacts with residues in the C-terminal domain of CaM but only a few contacts with one residue in the N-terminal domain. The structure suggests that substrate binding to the C-terminal domain is sufficient to cause the conformational changes in calmodulin that lead to activation of its targets.
PMID: 7803388 [PubMed - indexed for MEDLINE]
-
Cited by 10 PubMed Central articles
-
Normal modes for predicting protein motions: a comprehensive database assessment and associated Web tool.
Alexandrov V, Lehnert U, Echols N, Milburn D, Engelman D, Gerstein M.
Protein Sci. 2005 Mar; 14(3):633-43.
[Protein Sci. 2005]
-
NMR and molecular dynamics studies of the interaction of melatonin with calmodulin.
Turjanski AG, Estrin DA, Rosenstein RE, McCormick JE, Martin SR, Pastore A, Biekofsky RR, Martorana V.
Protein Sci. 2004 Nov; 13(11):2925-38.
[Protein Sci. 2004]
-
A molecular dynamics study of Ca(2+)-calmodulin: evidence of interdomain coupling and structural collapse on the nanosecond timescale.
Shepherd CM, Vogel HJ.
Biophys J. 2004 Aug; 87(2):780-91.
[Biophys J. 2004]
- » See all...
Structures reported by this article
Patient Drug Information
-
Trifluoperazine
Trifluoperazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Trifluoperazine is also used on...